PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
Zambia has a population of approximately 11.5 million citizens (US Department of State, 2007), and overall
HIV prevalence is nearly 16% among the general population and 13% among men (Zambia Demographic
Health Survey, 2002). Currently, there is very limited prevention for positives activities implemented by any
of our partners specifically targeting positives, negatives and out of school. It is apparent that as the
populations if PLWAs increase with availability of drugs those programs also incorporate prevention for
positives programs with proven success.
Funds will be used to run intensive prevention programs for negatives and positives including adult out of
school youth. Funds will be used to hire additional youth staff, provide mobility to underserved areas in
Livingstone and Lusaka, implement youth program in Siavonga in collaboration with other partners, do
community mobilization, obtain the necessary supplies and hire additional staff to carry out the work.
The following activity is newly proposed for FY 2008.This activity links with the Zambia Prevention, Care,
and Treatment Partnership PMTCT, ART, Counseling and Testing (CT), TB/HIV, and Laboratory Support
activities as well as with the Government of the Republic of Zambia (GRZ) and other US Government
(USG) partners.
Though AIDSRelief Project is primarily a provider of antiretroviral therapy (ART) services, this involves
treatment of Opportunistic Infections (OIs) including TB, STIs and others, as well as pain and symptom
management, and clinical care for severe malnutrition. This activity will strengthen and expand clinical
palliative care services in seven provinces. AIDSRelief Project will support 15 districts. AIDSRelief Zambia
has incorporated a Family Center Care Health approach to addressing the needs of Palliative Care in the
area of basic health care and support. Our Family Centered Care team has focused on trainings that are
designed to incorporate the entire family unit into the health care facility model. This approach develops
sustainable care as the family unit assumes greater health care support and responsibility for itself. This
approach has had impact on reducing stigma, encouraging more consistent follow-up, increased testing of
family members, and greater adherence among individual family members. As part of our comprehensive
care and treatment plan, the palliative care includes management of all OIs and follow-up of patients at
community level. Training and on-site mentoring on pain management has taken place and has been a
critical component of AIDSRelief program.
In FY 2007, AIDSRelief reached 41,000 clients with clinical palliative care services through support to 16
facilities in the 15 districts. In FY 2007, AIDSRelief trained 200 health professionals (doctors, nurses,
clinical officers) in ART/OI/Sexually Transmitted Infections (STI)/Pain management through full and
refresher curriculum. AIDSRelief follows the National Standards for ART and OIs. In addition, specific on-
site mentoring is conducted by the family-centered AIDS resident team.
In FY 2008, AIDSRelief will train 288 Health professionals in initial ART/OI management curriculum. In
addition, AIDSRelief Project will conduct specific customized training which will respond to the needs of the
treatment facilities based on the results of the Quality Assurance and Quality Improvement process.
In FY 2008, 48,000 clients will receive clinical palliative care services in 16 supported facilities. During FY
2008, AIDSRelief will consolidate on FY 2007 efforts by providing technical support to ensure quality
services and build capacity to manage clinical palliative care services. AIDSRelief Zambia will continue to
work with its national partner Churches Association of Zambia (CHAZ) as part of its sustainability plan. Key
elements of the work plan include transferring technical, managerial and financial skills to CHAZ and
secondment of technical staff for clinical and M&E direct support. In the same line with this plan, AIDSRelief
Zambia plans to initiate the development of HIV Residency for Zambian nationals to become expert in
clinical HIV including clinical palliative care.
Clinical palliative care activities will include these components: 1) strengthening palliative care services in
health facilities; 2) increasing referral linkages within and between ART facilities and community HBC and
hospice care; 3) participating in and assisting the MOH, the National AIDS Council to develop a strategy,
guidelines, and standard operating procedures for provision of quality clinical palliative care in ART sites
and services; and 4) increasing program sustainability with the GRZ.
In the first component, strengthening palliative care services within health facilities, AIDSRelief will continue
to support 16 ART facilities in 15 districts. In addition to the ART/OI/STI/TB training mentioned above,
health professionals will also be trained, using GRZ-approved curriculum, to provide cotrimoxazole
prophylaxis, symptom and pain assessment and management, patient and family education and counseling,
management of adult and pediatric HIV in the home setting, and provision of basic nursing services in clinic
settings as part of the overall package of clinical palliative care services. Pharmacy staff will be trained in
data collection/reporting and ordering, tracking, and forecasting HIV-related commodities to ensure
availability of critical medical supplies and drugs. AIDS Relief will also liaise closely with the USAID/Deliver
Project and Partnership for Supply Chain Management Systems (SCMS) on forecasting drug supply
requirements.
In the second component, increasing referral linkages within and between health facilities and communities,
AIDSRelief will build on Zambia's long history of working with Faith-Based Organizations (FBOs) and
Community-Based Organizations (CBOs) that provide home-based care for people living with HIV/AIDS
(PLWHAs). These organizations serve as critical partners for facility-based programs supported by GRZ
and USG. Therefore, as in FY 2007, AIDSRelief will work closely with these established entities to
strengthen referral networks linking clinical palliative care services with community-based programs. For
example, AIDS Relief will continue the implementation of the linkages and integration work plan with
Catholic Relief Services/SUCCESS RTL and RAPIDS to better link clinical services to related community
programs.
In the third component, AIDSRelief will continue its participation in and provision of assistance to the USG
Palliative Care Forum as well as coordinate with the Palliative Care Association of Zambia to develop a
national palliative care strategy, guidelines, and standard operating procedures. Through these efforts,
AIDSRelief aims to improve access to quality clinical palliative care services promote use of evidence-
based practices, share lessons learned in project implementation, and support the revision of national
palliative care guidelines and protocols in accordance with GRZ policies.
In the final component, increasing program sustainability with the GRZ, AIDSRelief will continue to work
with CHAZ to build on the quality assurance activities started in FY 2005. In FY 2008, in collaboration with
the GRZ and CHAZ, the AIDSRelief-supported sites will receive direct support from CHAZ to guarantee
consistent quality clinical palliative care services
The funding level for this activity in FY 2008 has increased from that of FY 2007. Only minor narrative
updates have been made to highlight progress and achievements.
Tuberculosis (TB) is a major cause of morbidity and mortality in people living with HIV and needs specific
attention. Routine quality testing of TB patients for HIV is an efficient means of identifying HIV in the
community. The major emphasis of this activity will be on Health Care Financing and Quality Assurance
and Supportive Supervision. Other emphases will include training, community mobilization/participation,
strengthening of networks and referral linkages, and activities that will contribute to infection control.
The following populations are targeted: health care providers (including Community Health Workers), faith-
based organizations, community-based organizations, and all persons affected by HIV and AIDS.
Based on the principle that all HIV positive persons in the CRS AIDSRelief program are screened for TB
based on symptoms and exposure history, and all patients being prepared for ARV drugs receive TB
screening, this activity will be implemented in the following components:
(1) Enhancing laboratory capacity to diagnose TB accurately;
(2) Establish and strengthen referral linkages between CRS AIDSRelief facilities and the Zambian
government TB directly observed treatment strategy (DOTS) sites to ensure timely diagnosis and treatment;
(3) Ensure accessibility to information, education, and communication (IEC) materials on the relationship
between TB and HIV at health facilities as well as surrounding communities;
(4) Enhance the capacity for the diagnosis of smear negative and extra-pulmonary TB based on national
program recommendations.
(5) Reduce the potential risk of nosocomial transmission among patients.
To ensure routine screening and accurate diagnosis of TB in all patients enrolled for HIV care at all 16 AIDS
Relief health facilities and four (4) CHAZ supported Health Facilities, this activity will involve building acid-
fast bacilli laboratory capacity and providing access to chest X-ray to diagnose sputum-negative cases of
TB. A few sites will benefit from small renovations as additional safety measures for lab workers. Additional
training to prepare providers to recognize extra-pulmonary TB in HIV+ individuals will also be conducted.
All laboratories will be equipped to perform sputum smear to detect acid fast bacilli and will be engaged in
quality assurance and quality improvement activities with nearby reference laboratories. Specifically, funds
will be used to strengthen laboratory infrastructure at AIDSRelief facilities to conduct TB diagnostic tests, to
ensure that chest X-ray is available for all sputum-negative individuals, especially those who qualify to
commence antiretroviral therapy, and to provide training and ongoing technical assistance to laboratory staff
in sputum diagnosis of TB, training all cadre of staff to identify potential TB cases and to make the diagnosis
(counselors, nurses, community health workers, treatment support specialists, etc). In addition, patients with
smear negative specimens but suggestive clinical signs will have their specimens referred to an outside
laboratory for culture.
Ensuring that patients diagnosed with TB at CRS AIDSRelief facilities have access to quality care involves
strengthening the capacity of the facilities to meet the special needs of persons living with HIV/AIDS and
TB. Special attention will be placed on patients who are on ARVs and anti-TB treatment simultaneously.
Funding towards this component will go to supporting training of all cadres of clinical staff (doctors, nurses,
counselors, treatment support specialists, and community health workers, etc.) on TB management
especially as it relates to the HIV positive patient, establishment of referral linkages for HIV patients
diagnosed with TB at CRS AIDSRelief sites on TB DOTS for community-level follow-up for care and
support, and developing and implementing joint strategies to assist with patient adherence to ARVs and anti
-TB drugs by utilizing community health workers, treatment support specialists and other community support
groups. It is further planned to strengthen the dual referral system between AIDSRelief facilities with HBC
for patients co-infected with HIV and TB. This will improve the linkages with other USG supported programs
like SUCCESS-RAPIDS. Additionally targeted co-infected TB/HIV patients will be linked with SUCCESS for
the provision of Ready to Use Therapeutic Food (RUTF) and complementary food.
Up to 60 health workers will receive specific training on TB/HIV as it relates to their job responsibilities. It is
estimated that a total of 4,000 persons living with HIV/AIDS will be treated for TB under CRS AIDSRelief
using drugs obtained through the National TB program and is not included in the budget. All patients who
are diagnosed and treated for TB under CRS AIDSRelief will be entered in the Zambian Government's
register with appropriate linkage of medical records between TB and HIV. Funds under the Strategic
Information activity will be used to implement the use of TB registers in all CRS AIDSRelief facilities, train
medical records staff, laboratory staff and clinicians on entering information on suspected cases, TB
screening, diagnosis, treatment, and follow-up laboratory tests for patients seen at the health facility.
The education and sensitization component under this activity will include the development of a
communication strategy to sensitize the communities served by CRS AIDSRelief on the linkage between TB
and HIV. Funds will be directed at working with local organizations to develop, print and distribute IEC
materials related to TB/HIV issues to communities and health facilities, conducting educational sessions at
support groups and other community-based groups, training in voluntary counseling and testing (VCT) and
other counselors to provide information on TB/HIV to their clients during counseling sessions. All sixteen
CRS AIDSRelief health facilities and four CHAZ supported facilities and surrounding communities will
benefit from having IEC materials available.
Funds will be used for infrastructure improvement at outpatient clinics (OPD) in five (5) CRS
AIDSRElief/CHAZ sites in order to reduce the risk of nosocomial transmissions among patients due to
congestion as a result of scale up.
The training of health staff and community volunteers providing care in both urban rural mission health
facilities will ensure sustainability of the program.
With the extra funding of $ 150,000 AIDSRElief will increase the capacity in three (2) CHAZ supported sites
and upgrade one (1) AIDSRelief site to conduct sputum investigations. 750 patients will be targeted.
Activity Narrative:
Patient care will include ensuring routine screening and accurate diagnosis of TB in all patients enrolled for
HIV care at the three (3) CHAZ supported Health Facilities, this activity will involve building acid-fast bacilli
laboratory capacity and providing access to chest X-ray to diagnose sputum-negative cases of TB. Three
(3) sites will benefit from small renovations as additional safety measures for lab workers and infection
control in the outpatient departments.
Specifically, funds will be used to strengthen laboratory infrastructure to conduct TB diagnostic tests, to
in sputum diagnosis of TB, training of staff to identify potential TB cases and to make the diagnosis
It is further planned to strengthen the dual referral system between AIDSRelief facilities with HBC for
patients co-infected with HIV and TB. This will improve the linkages with other USG supported programs
Targets set for this activity cover a period ending September 30, 2009.
The funding level for this activity in FY 2008 will remain the same as in FY 2007. Only minor narrative
Related activities: This activity also relates to activities in HBHC SUCCESS II, CRS HVTB, HTXS (track
1.0), CRS HTXS, CRS HKID and HLAB.
Based on the Zambian national HIV/AIDS strategic plan, there has been a low uptake of counseling and
testing (VCT). In FY 2008, AIDSRelief will aim to improve uptake of CT by increasing the availability of
counseling and testing in health facilities and through community outreach, through training of staff and
strengthening linkages with other services. This activity will be conducted in different clinical settings
including adult and pediatric antiretroviral therapy (ART), prevention of mother to child transmission
(PMTCT) and tuberculosis (TB), and sexually transmitted infection (STI) clinics. The suggested form of
testing would be as diagnostic routine testing with the option to opt-out. This is in conjunction with the
Government of the Republic of Zambia (GRZ) plans of introducing a more comprehensive approach and
increasing the number of people receiving CT services. Most of the rural mission hospital AIDSRelief sites
where AIDSRelief is currently working have TB or STI clinics where these activities will be implemented.
This activity will target persons affected by HIV/AIDS, faith-based organizations (FBOs), and community
health care providers. There are three main components to this activity: 1) provision of comprehensive CT
services within hospital settings and in the surrounding communities; 2) training of staff to provide CT
services; and 3) the strengthening and expansion of linkages to ensure continuity of care for persons who
test HIV positive.
The first component of this activity is to provide comprehensive CT through integrated VCT services within
hospital settings and in the surrounding communities, which will involve supporting 16 hospitals to provide
CT for diagnostic purposes for persons attending in-patient and out-patient services. Routine CT will be
offered to the following principal target populations: pregnant women, patients diagnosed with STIs, and TB
patients, as well as family members of persons living with HIV/AIDS (PLWHA) and self-referred members of
the general public. To enhance patient uptake, VCT services will be offered at community outreach
activities in the surrounding communities, and home testing for families of PLWHA. Community outreach is
carried out during the important health calendar days. A full package is delivered by the clinical team
including community mobilization, drama show focused on access to treatment and care. Those positives
would be referred on site for continued care and ART services. Besides the clinical component, they are
linked to the support system within the community..
The program will continue to use rapid test with same day results. Funding under this activity will
specifically go to support the procurement of test kits for sites not linked with the government pipeline of
supplies and the cost to conduct community-level testing. Through this component support will be provided
to 16 service outlets to train 64 individuals in CT, conduct and provide CT services to an estimated 28,000
individuals.
The second component of this activity is the training of staff at the hospitals to provide CT and the training
of supervisory staff at the hospital to ensure that minimum quality standard of services are met.
Counselors, laboratory staff, and VCT counselors will be trained on how to conduct pre-test and post-test
counseling, on the correct use of the HIV rapid test kits, on providing full and accurate information on HIV
prevention, and also on how to make the appropriate referrals for patients and their families who test either
positive or negative. The training of trainer concept will be used for persons involved in workshops. This
component of the activity will work to train 64 individuals in CT. All VCT training activities will use the
standard Zambian VCT guidelines and testing protocols.
The final component is strengthening and expanding linkages to ensure continuity of care for all persons
accessing CT through AIDSRelief. Strong linkages will be formed with other CRS HIV-related activities
including palliative care provided by the SUCCESS and RAPIDS projects, as well as other CRS orphans
and vulnerable children projects conducted by the CHAMP and RAPIDS projects (HKID activity #8947).
AIDSRelief will also work to establish linkages with other community groups to ensure social, psychological,
legal support, and income generation activity which is available for all patients who test positive for HIV.
Non disclosure makes it very difficult for referrals to other services. The programs plan to intensify
disclosure counseling including couple counseling. Assessment of the social status of clients will be done to
determine the barriers to disclosure. The program will continue to provide Information during group
education sessions on the benefits of disclosure. One on one counseling session will be specially initiated
for clients in need. Special emphasis on spouse notification will be encouraged.
Funds for this component will be used to establish and strengthen referral networks between community
groups and social service providers, as well as with other related projects conducted by CRS and other
USG partners.
Related activities: This activity links to AIDSRelief-Zambia .
The funding level for this activity in FY 2008 will decrease since FY 2007 this is due to the recent drug
accreditation of all AIDSRelief sites that can now access ARV Drugs through the government system.
AIDSRelief provides HIV care and services, including antiretroviral therapy (ART), primarily to the most
marginalized populations through faith based organizations in rural areas. AIDSRelief works through the
local partner treatment facility (LPTF) to provide treatment and care and builds the capacity of the treatment
facility to provide this care as a means of building a sustainable care system. In the initial phases of the
program, the antiretroviral drugs were purchased directly by AIDSRelief, in a system parallel to the Ministry
of Health (MOH). However in the spirit of supporting the Three Ones principle and in order to ensure the
development of a sustainable system, beginning in FY 2006, AIDSRelief agreed with the MOH that new
patients initiated on treatment in the AIDSRelief-supported sites would receive first-line and second-line
generic drugs through the Central Medical Stores logistics supply system. The U.S. Government through
JSI Deliver has strengthened the central logistics procurement and supply of antiretroviral medications.
In FY 2008, all AIDSRelief supported sites will have access to government supply pipeline of drugs.
AIDSRelief will keep $212 000 for ART drug supply as a buffer stock. This backup is intended to help
avoid emergency stock-outs as the Government of the Republic of Zambia stock reporting and drug
forecasting systems are being strengthened. As of June 2007, approximately 2,412 patients (adult and
pediatric) were on second-line and/or drug combinations containing second-line antiretroviral treatment.
Churches Health Association of Zambia will continue to store the buffer stock and will also distribute drugs
to AIDSRelief facilities, in support of the Central Medical Stores logistics supply system.
In FY 2008, AIDSRelief will provide ART for 21,000 patients at 16 faith-based hospitals and other clinics,
including the maintenance of 15,000 patients from 2007 and the expansion of ART to an additional 6,000
patients in 2008-2009.
The funding level for this activity in FY 2008 has increased since FY 2007. Funding from ARV Drugs has
been moved to this activity since all AIDSRelief sites are now ARV Drug accredited and can receive
supplies from the government system.
This activity relates to CRS SUCCESS Project. Funding supports scaled up activities from track 1.0.
AIDSRelief has continued to contribute to the United States Government's HIV/AIDS strategy in Zambia by
activating and supporting 16 local partner treatment facilities (LPTFs) and additional satellite facilities to
provide antiretroviral therapy (ART), as well as HIV care and services in remote areas. As of July 2007,
AIDSRelief had 13,880 patients actively on ART out of which 895 were children and 31,583 patients were
receiving basic care and support.
AIDSRelief continues to support the Zambian government's HIV strategy and participates in multiple
technical working groups and technical committees, including: the ART National Guidelines Working Group;
National AIDS Council Resistance Surveillance Working Group; the Medical Council Site Accreditation and
Provider Certification Group; the National Laboratory Instrumentation Working Group; the National Pediatric
ART Regimen Choice Committee; the National Pediatric ART/OI Training Curriculum Development Group.
In keeping with its commitment to ensure that care and services continue to be delivered at a high standard,
AIDSRelief has implemented a Quality Assurance/Quality Improvement (QA/QI) program at its LPTFs.
AIDSRelief also participates in the JHPIEGO-led ART Quality Improvement Program (AQIP). This included
conducting formal chart reviews at facilities that were activated in FY 2004 and performing viral load
measurements on 10% of patients who had been on treatment for more than nine months. Analysis of the
data showed a viral load suppression of 88 %. In addition, by using the pharmacy database, partners have
been able to track would-be defaulters easily and implement early interventions such as home visits and
counseling. By keeping track of the attrition rates, AIDSRelief and their partners have been able to
implement timely interventions at LPTFs, such as community mobilization and revision of adherence
strategies.
Since the initiation of ART services at all our LPTFs we have installed, trained, and assisted with
maintenance of dry chemistry analyzers for Creatinine and ALT determination. Since abnormal renal
function requires dose adjustment with many ARV drugs, we have invested in this capacity since year one.
All AIDSRelief sites have been performing Creatinine values routinely and will continue with this monitoring.
Building on FY 2007, AIDSRelief will provide AIDS treatment services primarily through faith-based facilities
that typically treat the most marginalized populations and provide services in rural areas. The cost of
providing care in these areas is usually high due to poor road infrastructure that makes it difficult and costly
to transport supplies.
Although not directly funded in Zambia for PMTCT, training and integration of PMTCT programs into our
Family-centered care health strategies and emphasis on building linkages between all infant and child
services have occurred and will continue. Special link has been made with CHAZ to provide PMTCT
services at AIDS Relief supported sites. The incorporation of Dry Blood Spot (DBS) testing for infant
diagnosis has availed an opportunity to truly develop tracking systems that can monitor the impact of
PMTCT programs on transmission. Our PMTCT approach has facilitated increased enrollment of all ART
eligible pregnant women on full ART courses to be on full ART courses so as to maximize the benefit of
PMTCT while minimizing the impact of ARV drug resistance to the mother and infant.
During FY 2008, AIDSRelief will scale up in the existing sites providing ART to 21,000 patients in 16 faith-
based and non-faith based hospitals and clinics, this will include the maintenance of 15,000 patients from
FY 2007 and the expand 6,000 ART patients as an additional number. By the end of FY 2008, AIDSRelief
Zambia will have provided HIV care to a total of 48,000 individuals. CRS will use private funds and
foundation resources for infrastructure improvement to accommodate the expanded number of patients in
three (3) health facilities.
Pediatric populations and issues will continue to be addressed through focused trainings on early
identification of children at risk for HIV at the rural health MCHC sites, PMTCT programs, OPD clinics, and
in-patient pediatric wards. Trainings for medical officers, clinical officers, and nurses will be regularly
conducted that are designed to increase care management skills of non-pediatric health care providers.
These trainings will be focused on those LPTFs with reported low pediatric enrollments or had requested for
assistance. It is hoped that, with these funds AIDSRelief will reach 2100 pediatric patients expected by the
end of the fiscal year.
In FY08, AIDS Relief will continue to focus on Quality assurance at several different levels. Since durable
viral suppression and adherence to therapy are the cornerstones of successful treatment of HIV with ART,
AIDSRelief Zambia will continue to invest in extensive chart review, by conducting adherence surveys as
well as doing viral load sampling on a randomized sample of patients on ART at each site. The data is then
analyzed site by site and comparisons are made with the data from other AIDSRelief countries. Sites are
then assisted with potential areas for support and improvement. Concurrently, at the LPTF a Quality
Assurance/Quality Improvement program is developed with local ownership to assist with the identification
of site specific strengths and weakness in the multiple departments that impact care and treatment. In
conjunction with the MOH, CDC, and other implementing partners AIDSRelief Zambia a ‘best practice'
model of QA/QI programs is being developed for implementation at the national level. Currently AIDSRelief
Zambia is also implementing a wide scale laboratory quality control program to address sustainable quality
control in the rural laboratory setting
AIDSRelief will continue with CHAZ activities related to joint involvement at site level for sustainability
purposes. AIDS Relief and CHAZ will continue to implement elements of the sustainability work plan which
include transferring technical, managerial and financial skills to CHAZ and secondment of technical staff for
clinical and M&E direct support. In line with the sustainability plan, AIDSRelief in collaboration with the
Ministry of Health (MOH) and the University Teaching Hospital (UTH) plans to use the funds to develop a
residency fellowship program to prepare Zambian doctors to become HIV specialists.
Adherence to treatment will be ensured through linkages with home-based/palliative care programs
established by CRS and other partners. These linkages are critical to monitoring the treatment adherence
and preventing possible complications as a result of non-adherence. The treatment support specialist at the
clinical level will be working with community health workers and volunteers from the existing palliative care
programs to ensure the proper treatment monitoring as well as the ART education of patients and their
buddies. Creating satellite point of service will help further expand the reach to patients in remote and rural
Activity Narrative: areas of Zambia. ART services will continue to be enhanced by twinning sites from different geographical
areas. This will ensure sharing experiences and lessons learned and will enable further capacity building of
LPTFS. Training centers will continue to serve as resource centers for building the capacity of medical staff
from other LPTFS as well as other ART providers in country offering more sophisticated services to patients
on treatment. In FY 2007, AIDSRelief had four ART sites accredited by the Medical Council of Zambia and
will therefore receive ARV drugs from the Ministry of Health supply. Therefore $ 1,615,895 meant for ARV
drugs has been moved to scale up ART services in the 16 sites AIDSRelief is supporting.
Traditionally HIV prevention efforts have focused on HIV-negative individuals. "Positive Prevention" aims to
protect the health of HIV-infected individuals and prevent the spread of HIV to sex partners. The rapid scale
-up of care and treatment has created an important opportunity to reach many HIV-infected individuals and
clinic-based prevention interventions aimed at people infected with HIV will be included together with
counseling on ARV adherence and alcohol use.
In FY 2008, the data migration from CAREWare to government SmartCare system would by then complete
and all AIDSRelief supported sites will use SmartCare.
These services are critical to providing quality HIV care and treatment, and have been an integral part of the
AIDSRelief program since its inception. This proposal is also contingent upon continued central funding
through HRSA at existing levels.
The funding level for this activity in FY 2008 has increased since FY 2007. Narrative changes include
updates on progress made and expansion of activities.This activity relates to: EGPAF SI, JHPIEGO SI,
Ministry of Health (MOH), Technical Assistance - Centers for Disease Control and Prevention (CDC), and
COMFORCE
Constella Futures leads the monitoring and evaluation (M&E) component for Catholic Relief Services (CRS)
AIDSRelief Zambia. Using in-country networks and available technology, Constella Futures is building
strong patient monitoring and management systems that are used to collect data and track strategic
information from the Points of Service (POS). Strategic information includes indicators from the President's
Emergency Plan for AIDS Relief (PEPFAR), other United States Government (USG) agencies in
conjunction with the Ministry of Health (MOH), and AIDSRelief specific project indicators. This collective
information supports the provision of high quality HIV/AIDS care and treatment, ensures drug availability,
tracks patient and program progress, and provides accuracy in reporting to both the USG and NMOH
(former Central Board of Health). While reporting on indicators to donors and governments is an essential
secondary objective, the primary aim of collecting strategic information (SI) is to assist clinicians and clinic
managers to provide high quality HIV/AIDS care and treatment, assist in chronic disease management,
monitor viral resistance, and ensure durable viral suppression.
With the MOH establishing the SmartCare electronic medical record (EMR) application as the national
standard, all AIDSRelief supported sites will convert to SmartCare.
The program will hire temporary staff to enter data into the new SmartCare in case some date fields from
CAREWare has not been properly migrated.
In FY 2008 the SI team will focus their efforts on maintaining the standardized national M&E systems that
will be used across all AIDSRelief sites. This will include the mentoring of already trained as well as training
of new facilities in using the forms and software adopted at national level.
Constella Futures provides training and on-site technical assistance to local partner treatment facilities
(LPTFs) in order to build in-country capacity and enhance paper-based and automated HMIS. Focusing
efforts on capacity building activities will ensure that LPTFs are skilled in comprehensive data management,
including data collection, validation, analysis, and reporting. LPTFs will also develop an understanding of
the minimum data requirements for donor purposes and high-quality clinical management. It is Constella
Futures's intent to ensure that accuracy in data management is understood at all levels at the LPTFs
because it is an essential component of monitoring patient progress and ensuring accuracy in reporting.
In year 2008/9 Constella Futures will carry out a program evaluation, which will cover program
implementation, outcome and impact assessments. The evaluation will incorporate the findings from Quality
Assessment/Improvement (QA/QI), Quality of Life Analysis (QLA) and Life Table Analysis (LTA).